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Abstract
Background: Multimorbidity is highly relevant for both service commissioning and clinical decision-making.
Optimization of variables assessing multimorbidity in order to enhance chronic care management is an unmet
need. To this end, we have explored the contribution of multimorbidity to predict use of healthcare resources at
community level by comparing the predictive power of four different multimorbidity measures.
Methods: A population health study including all citizens ≥18 years (n = 6,102,595) living in Catalonia (ES) on 31
December 2014 was done using registry data. Primary care service utilization during 2015 was evaluated through
four outcome variables: A) Frequent attendants, B) Home care users, C) Social worker users, and, D) Polypharmacy.
Prediction of the four outcome variables (A to D) was carried out with and without multimorbidity assessment. We
compared the contributions to model fitting of the following multimorbidity measures: i) Charlson index; ii)
Number of chronic diseases; iii) Clinical Risk Groups (CRG); and iv) Adjusted Morbidity Groups (GMA).
Results: The discrimination of the models (AUC) increased by including multimorbidity as covariate into the
models, namely: A) Frequent attendants (0.771 vs 0.853), B) Home care users (0.862 vs 0.890), C) Social worker users
(0.809 vs 0.872), and, D) Polypharmacy (0.835 vs 0.912). GMA showed the highest predictive power for all outcomes
except for polypharmacy where it was slightly below than CRG.
Conclusions: We confirmed that multimorbidity assessment enhanced prediction of use of healthcare resources at
community level. The Catalan population-based risk assessment tool based on GMA presented the best
combination of predictive power and applicability.
Keywords: Chronic care, Comorbidity, Primary care, Health service utilization, Risk assessment
Background
Multimorbidity, defined as the coexistence of two or
more diseases in a given individual, is a common feature
in chronic patients [1, 2] that increases with age [3] and
is well recognized as one of the major burdens on health
systems worldwide [4, 5]. Multimorbidity shows well
established associations with both high use of healthcare
resources and poor patient prognosis [6]. Regarding its
impact at community level, multimorbidity shows posi-
tive correlations with number of outpatient visits [7],
polypharmacy [8] and with patients’ frailty [9]. The latter
being a strong modulator of the need for both homecare
and social support services [10, 11].
Prevention and management of multimorbidity requires
implementation of care coordination, which involves inte-
gration of health and social services, in order to face the
challenges associated with the increasing prevalence of
chronic disorders [12, 13]. In this regard, the efficient im-
plementation of the chronic care model appears as the
best way to ensure health value generation, equity and
sustainability of health systems [14, 15].
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It is acknowledged that appropriate assessment of
multimorbidity [3, 7, 16] constitutes a core need in order
to enhance service commissioning, as well as other
health policy issues associated with large scale deploy-
ment of the practicalities of the chronic care model. To
this end, the current research uses a population-health
approach to compare the predictive role of four well-
defined modalities of multimorbidity assessment on use
of healthcare resources in Primary Care. Moreover, the
current study is to provide an objective assessment of
the new tool for population-based health risk assessment
(GMA, Adjusted Morbidity Groups), developed in Cata-
lonia and implemented in Spain since 2015, in terms of
prediction of use of healthcare resources in primary
care.
Methods
Data source and study population
Since 2011, the Catalan Health Department surveillance
system (CHSS) collects detailed information on health-
care usage for the entire population of Catalonia (North-
Eastern Spain, 7.5 million inhabitants) [17]. It includes
information from hospitalization, primary care visits,
emergency department visits, skilled nursing facilities,
palliative care and the mental health services, informa-
tion on pharmacy prescription and expenditure, and a
registry on the billing record also encompassing out-
patient visits to specialists, home hospitalization, medical
transportation (urgent and non-urgent), ambulatory re-
habilitation, respiratory therapies and dialysis.
The registry has an automated data validation system
that checks the consistency of the data and identifies po-
tential errors. Moreover, as this information is used for
provider payment purposes, external audits are per-
formed periodically to ensure the quality and reliability
of the data. The CHSS is also used to elaborate, on a
six-month basis, the regional population-based health
risk assessment tool, known as GMA (Adjusted Morbid-
ity Groups), which generates the health risk strata pyra-
mid of the general population of Catalonia [18, 19].
For the purposes of the current study, all adult resi-
dents (≥18 years) in Catalonia on 31st December 2014
were included in the analysis. This yielded a final study
population of 6,102,595 cases. The research was under-
taken under the umbrella of the Nextcare project [20],
approved by the Ethical Committee for Human Research
at Hospital Clínic de Barcelona (HCB/2018/0805). We
used retrospective de-identified data from administrative
databases and, therefore, the need for informed consent
was waived.
Multimorbidity assessment
The study compared the predictive power of four differ-
ent measures assessing multimorbidity: the Charlson
index [21], number of chronic diseases, Clinical Risk
Groups (CRG) [22], and GMA [18, 19, 23].
The Charlson index was included because it is the
most broadly used parameter to assess multimorbidity
[3]. This index was initially developed in hospitalized pa-
tients to estimate mortality prognosis based on age and
the fixed weights of 20 specific disorders [21]. The
current study used the 2007 updated version of the
Charlson index [24] adapted to primary care, further re-
fined in 2014 [25].
The number of chronic diseases was based on the
Clinical Classifications Software (CCS) [26] and the
Chronic Condition Indicator (CCI) [27] elaborated by
the Healthcare Cost and Utilization Project (HCUP) of
the Agency for Healthcare Research and Quality
(AHRQ). The CCS aggregates all diagnosis codes into
262 mutually exclusive, clinically homogeneous categor-
ies; whereas the CCI allows to determine if a diagnosis is
a chronic condition. The combination of CCS and CCI
provides the number of chronic conditions for a given
subject.
The study also included information provided by the
Clinical Risk Groups (CRG), elaborated to predict total
annual health costs for large patient groups [22]. CRG
consist of mutually exclusive risk groups estimating past
and future use of healthcare resources. It is of note that
calculation of CRG required information on diagnosis
across the Catalan health system during 2014, as well as
data on pharmacological prescriptions during the same
period. Only estimation of future use of resources was
considered in the current study.
Finally, we assessed the role of the morbidity grouper
developed in Catalonia (GMA) [18, 19]. GMA classifies
the population into 31 mutually exclusive categories
based on both multimorbidity and levels of patient com-
plexity (see detailed information on the GMA’s algo-
rithm and validation in Additional file 1: Figures S1–S3).
Outcome variables
The outcome variables considered in the current study
were: (A) Frequent attenders in primary care, defined by
≥12 visits to the primary care team irrespective of the
professional (physician, nurse, physiotherapist, etc.) and
the type of visit (primary care unit, home, remote) during
the year 2015; (B) Patients receiving home care support
either by the primary care team, emergency services or
teams specialized in geriatric and palliative care during
2015; (C) Patients receiving social support visits defined as
patients that performed visits to the community-based so-
cial care worker during 2015; and, (D) Patients receiving
polypharmacy, defined by prescription of more than eight
drugs during the year 2015. All the outcome variables
were treated as dichotomous.
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A sensitivity analysis carried out to determine the cut-
off points for A) and D) showed similar results for per-
centiles 95 and 85. The later (P85) was used in the study.
The analysis of patients receiving social support was lim-
ited to the primary care centres that had one social
worker assigned to the staff (n = 4,776,005) due to the
fact that in some geographical areas social support is dir-
ectly linked to city council services and information was
not available for the current analysis.
Data analysis
The current study consisted of a prospective analysis of
existing registry information at 31 December 2014 to
calculate the four multimorbidity measures (Charlson
index, number of chronic diseases, CRG and GMA) and
the events occurring during the entire 2015 for the four
outcomes variables (A to D) described above. Results are
expressed as mean values, standard deviations and 95%
confidence intervals.
Logistic regressions were carried using each outcome
variable as the dependent variable. For each model, the
following covariates were considered: (i) age, (ii) sex, and
(ii) socioeconomic level, as well as all first order interactions
among those covariates. Moreover, the individual contribu-
tions of the three multimorbidity measures to the perform-
ance of the resulting predictive models was assessed, with a
log-likelihood ratio test, through its inclusion as a covariate
in the regression analyses. Accordingly, the model with age,
sex and socioeconomic status was the baseline model. Age
was analysed as a categorical variable grouped in 5-year in-
tervals except for the two extreme periods, 18–19 years
and > 94 years. Socioeconomic level was calculated as aver-
age income of all the residents living in the primary care
area and expressed as a categorical variable using five levels
[28]. It is of note that multimorbidity measures were in-
cluded in the predictive modelling as categorical variables
to allow for possible non-linearity in the relationship
between multimorbidity and the relevant outcome variable.
To evaluate the performance of the resulting predictive
models, we calculated the Akaike information criterion
(AIC) [29], the deviance-based R-square (R2) and the area
under the receiver operating characteristic (AUROC)
curve [30].
Statistical analyses were performed using SPSS soft-
ware, version 18.0. All statistical tests and confidence in-
tervals were constructed with a type I error (alpha) level
of 5%, and p-values < 0.05, were considered statistically
significant.
Results
The study group included 6,102,595 cases with an aver-
age age of 49.1 ± 18.2 years, 51.3% women with a mean
age of 50.3 ± 18.9 years. Main descriptive statistics for
each of the outcome variables is indicated in Table 1
(see detailed information in Additional file 1: Tables S1–S6).
Figure 1 displays the distributions of the outcome vari-
ables (A to D) by age and sex. It is of note that use of
healthcare resources was slightly higher in young women
than in men, but sex differences in terms of use of
healthcare resources vanished above 65 years, except for
use of home care services that was also higher in women
above this age threshold. Table 2 describes age and sex
distributions by multimorbidity measures considered in
the current study.
The contributions of each multimorbidity measure to
explain the outcome variables is indicated in Table 3.
The first row of the table indicates model fitting (AIC,
R2 and AUC) for each outcome variable (columns)
against a model containing age, sex, socioeconomic level
and all first order interactions among those covariates
without taking into account multimorbidity (baseline
model). The corresponding values of these statistical
measures when each of the four multimorbidity mea-
sures is added as a covariate are displayed in the subse-
quent rows, from 2nd to 4th. It is of note that lower
values for AIC and higher values for both R2 and AUC
indicate enhanced model fitting by including the corre-
sponding multimorbidity variable. In general, the three
statistics (AIC, R2 and AUC) used to assess model fitting
showed acceptable concordance within each multimor-
bidity measure.
The results displayed in Table 3 indicate that multi-
morbidity assessment provides a significant enhance-
ment of predictions irrespective the measure applied.
The comparisons among the three multimorbidity mea-
sures indicate that the best results were obtained with
the use of GMA except for patients receiving polyphar-
macy, where GMA performed slightly below CRG.
Discussion
Main findings
To the best of our understanding, the current study has
generated two relevant findings. Firstly, the results con-
sistently confirm that inclusion of multimorbidity as a
covariate generates a significant enhancement of estima-
tions of use of healthcare resources in Primary Care.
Secondly, comparisons among the different multimor-
bidity measures indicate that GMA provided better dis-
crimination and predictive power than the other
multimorbidity measures, for all the outcome variables ex-
cept for those patients receiving polypharmacy. For this
outcome, the contribution of CRG was only slightly higher
than that of GMA. It is of note, however, that GMA shows
higher applicability than CRG because the use of the
former does not require information on drug prescription.
We acknowledge that predictive modelling based on
registry data (CHSS) showed moderate robustness since, in
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the best scenario, it can only explain a rather modest per-
centage of the overall individual variability. Consequently,
the study suggests the need for exploring synergies between
the GMA grading system and functional status (i.e. mobil-
ity, strength, cognitive status), as well as clinical informa-
tion, to enhance health risk assessment and service
selection in the clinical arena, as analysed in detail in [18].
Contributions beyond the current state of the art
As mentioned, the current research supports previous
findings indicating that assessment of multimorbidity
enhances predictive modelling of use of healthcare and
social support resources at community level as com-
pared to approaches based only on demographics. It can
be speculated that the modest performance of the Charl-
son index in the study can be partly explained by the
fact that its calculation is based on a reduced number of
disorders (n = 20) using fixed-weights in each of them
and focused only in mortality.
The number of chronic diseases, despite its simplicity,
shows better predictive value than the CRG for most of
the outcomes, except for polypharmacy. It is of note,
however, that the GMA shows the best performance.
While several studies have analysed the contribution
of the Adjusted Clinical Groups (ACG) System [31] as a
multimorbidity index for prediction of use of healthcare
resources [3, 32], there are few analyses assessing the
role of CRG as multimorbidity index. Orueta et al. [9]
have reported that CRG behaves similarly to ACG for
prediction of use of healthcare resources in primary care.
As alluded to above, the current research indicates lower
performance for CRG as compared to GMA, except for
polypharmacy outcome.
Strengths and weaknesses of the study
The clinical focus of the study assessing main outcome
variables, namely: (i) Frequentation in Primary Care, (ii)
Integration with social support services; and, (iii)
Pharmacological prescription, should be considered a
novelty and, consequently, a strength of the current re-
search. Also, the characteristics of the source dataset in
terms of quality of the CHSS registry information and
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extension of the dataset should be considered as key fac-
tors providing robustness to the predictive modelling.
We acknowledge, however, that assessment of social
support services shows some limitations since it does
not include the entire study population. Moreover, the
covariate on socioeconomic level did not rely on individ-
ual information. Instead, it was based on average data of
the primary care area.
We also acknowledge that GMA, as well as other multi-
morbidity indices, show limitations for risk assessment of
specific subsets of individuals like children or patients with
mental disorders. However, undergoing research on men-
tal illnesses is opening novel perspectives in this area.
Implications beyond the current study
The rather modest amount of inter-individual variability
explained by the current predictive modelling seems to
indicate that integration between registry data from the
CHSS and electronic medical records of healthcare pro-
viders emerge as a high priority goal in order to enhance
clinical predictions that may facilitate links between
health risk predictive modelling and integrated care ser-
vice selection [18]. This approach should pave the way
toward enhanced risk assessment with huge positive im-
plications on clinical management of chronic patients by
assisting health professionals in clinical decision-making
and in optimizing their agendas.
Besides the high potential of multimorbidity assess-
ment in the clinical scenario, the current approach
shows also interest for macro level management of
chronic conditions. For example, it can be extremely
useful in several areas, namely: (i) service commis-
sioning, (ii) design of reimbursement incentives; (iii)
benchmarking among providers; (iv) propensity score
statistical weighting in studies carried out in a real
world scenario [33], etc. But, it has also shown to be
useful for linking macro and micro level management
for the design of services with case finding purposes
addressing patients with high risk of undesirable
health events [19].
It should be highlighted that, besides the predictive
performance provided by the GMA in the current study,
the rationale behind its use, against alternative health
risk assessment tools, is that GMA complies with four
main recommended criteria [18], namely: (i) Population
health approach (uses the entire population of 7.5 M
inhabitants of the region); (ii) Publicly owned with-
out licensing constraints; (iii) Based on open source
computational algorithms; and, iv) Adjusted morbid-
ity grouper that relies mostly on statistical criteria,
as opposed to other tools that include expert-based
Fig. 1 Distribution of the outcome variables in the study population by age (y-axis) and sex (x-axis): a: Frequent attendants (> 12 primary care
visits) (%); b: Home care users (%); c: Social worker users (%); d: Polypharmacy patients (%)
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coefficients, thus facilitating quick transferability to
other territories.
Conclusions
The current study confirms the impact of multimorbid-
ity assessment for enhanced predictive modelling of use
of healthcare resources in Primary Care through a popu-
lation health approach. Moreover, the research indicates
the high potential of GMA in terms of performance and
applicability.
Supplementary information
Supplementary information accompanies this paper at https://doi.org/10.
1186/s12875-020-01104-1.
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